OHRP Issues Two Determination Letters

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

OHRP Issues Two Determination Letters

J.W. Schomisch

September 23, 2022 at 04:26 PM EST

The HHS Office for Human Research Protections (OHRP) sent Determination Letters to two universities Sept. 16. In both cases, the agency found no violations of federal regulations. A letter to Leland Stanford Junior University closed out a not-for-cause virtual site evaluation of the university’s Human Research Protections Program (HRPP), which was conducted from Aug. 24, 2021... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

OHRP Issues Two Determination Letters

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT